Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin

BACKGROUND: Statins are the mainstay hypercholesterolemia treatment and reduce the risk of cardiovascular events in patients. However, statin therapy is often interrupted in patients experiencing musculoskeletal pain or myopathy, which are common in this patient group. Currently, the standard tests...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Dominic, Guertin, Jason R., Iliza, Ange Christelle, Fanton-Aita, Fiorella, LeLorier, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5250641/
https://www.ncbi.nlm.nih.gov/pubmed/27798813
http://dx.doi.org/10.1007/s40291-016-0238-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5250641/
https://www.ncbi.nlm.nih.gov/pubmed/27798813
http://dx.doi.org/10.1007/s40291-016-0238-8

Ejemplares similares